Ideaya Biosciences
Clinical trials sponsored by Ideaya Biosciences, explained in plain language.
-
New drug IDE574 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called IDE574 in people with advanced solid tumors (like lung, prostate, and colorectal cancers) and a specific type of breast cancer (ER+, HER2-). The goal is to see if the drug is safe and can shrink tumors. About 160 participants will receive IDE574…
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New drug may save eyes and vision in rare eye cancer trial
Disease control Recruiting nowThis study tests a drug called darovasertib given before standard surgery for people with a rare eye cancer called uveal melanoma that hasn't spread. The goal is to see if the drug can prevent vision loss and help patients keep their eye instead of needing it removed. About 520 p…
Phase: PHASE3 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Ab…
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New targeted drug shows promise for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study tests a new drug called IDE849 in people with small cell lung cancer and other tumors that have a protein called DLL3. The drug is given alone or with other medicines to see if it is safe and works. About 208 adults whose cancer got worse after standard treatment will …
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 28, 2026 13:08 UTC